Therefore, this meta-analysis aims to assess the role of SGLT-2 inhibitors and GLP-1 receptor agonists in the prevention or delay of type 2 diabetes mellitus in patients classified as prediabetics. This evidence concerns the gene GLP1R and diabetes mellitus.